ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

FRLN Freeline Therapeutics Holdings PLC

6.48
0.00 (0.00%)
15 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Freeline Therapeutics Holdings PLC FRLN 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 6.48 09:00:00
개장가 저가 고가 종가 전일 종가
6.48 6.48
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:00GLOBEFreeline to Present New Data on its Gaucher and Parkinson’s..
26/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
23/02/202406:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
23/02/202406:28EDGAR2Form POS AM - Post-Effective amendments for registration..
21/02/202405:22EDGAR2Form SC 13E3/A - Going private transaction by certain..
20/02/202421:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/02/202421:00GLOBEAcquisition of Freeline by Syncona Becomes Effective
13/02/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/02/202402:00GLOBEFreeline Shareholders Approve Acquisition by Syncona
19/01/202406:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/01/202406:17EDGAR2Form SC 13E3/A - Going private transaction by certain..
09/12/202307:21EDGAR2Form SC 13E3 - Going private transaction by certain issuers
01/12/202322:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202323:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202321:30GLOBESyncona to Acquire Freeline Therapeutics
25/10/202319:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202315:01GLOBEFreeline Presents Positive New Data from Phase 1/2 GALILEO-1..
18/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202320:00GLOBEFreeline to Present New Clinical Data for FLT201 in Gaucher..
07/10/202305:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202320:00GLOBEFreeline Reports Positive Initial Clinical Data from First..
15/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/08/202320:00GLOBEFreeline Reports Second Quarter 2023 Financial Results and..
08/08/202320:30GLOBEFreeline Therapeutics to Host Second Quarter 2023 Financial..
31/07/202320:30GLOBEFreeline to Participate in Upcoming Investor Conferences
25/07/202320:30GLOBEFreeline to Host Virtual KOL Event on its Gene Therapy..
26/06/202320:30GLOBEFreeline Announces First Patient Dosed with Its Novel Gene..
02/06/202321:00GLOBEFreeline to Present at 2023 Jefferies Healthcare Conference
30/05/202320:30GLOBEFreeline Reports First Quarter 2023 Financial Results and..
22/05/202321:00GLOBEFreeline Granted ILAP Designation in United Kingdom by MHRA..